Renovacor, Inc. financial data

Industry
Biological Products, (No Diagnostic Substances)
Location
201 Broadway, Suite 310, Cambridge, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Chardan Healthcare Acquisition 2 Corp. (to 9/3/2021), Chardan Healthcare Acquisition III Corp. (to 1/16/2020)
Latest financial report
10-Q - Q3 2022 - Nov 10, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.36K %
Debt-to-equity 28.6 % -62%
Return On Equity -24.6 % +72.5%
Return On Assets -19.2 % +8.42%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 17.3M shares +0.08%
Common Stock, Shares, Outstanding 16.8M shares +0.08%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 17.5M shares +78.5%
Weighted Average Number of Shares Outstanding, Diluted 17.5M shares +78.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 24M USD +154%
General and Administrative Expense 14.1M USD +102%
Operating Income (Loss) -38.1M USD -199%
Net Income (Loss) Attributable to Parent -13.2M USD +5.43%
Earnings Per Share, Basic -0.87 USD/shares -4.82%
Earnings Per Share, Diluted -0.87 USD/shares -4.82%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 53.7M USD -37%
Assets, Current 55.7M USD -36.7%
Property, Plant and Equipment, Net 1.44M USD +7105%
Operating Lease, Right-of-Use Asset 484K USD
Other Assets, Noncurrent 163K USD
Assets 57.7M USD -34.4%
Accounts Payable, Current 3.23M USD +115%
Employee-related Liabilities, Current 1.99M USD +397%
Accrued Liabilities, Current 3.95M USD +80.6%
Liabilities, Current 8.43M USD +129%
Operating Lease, Liability, Noncurrent 265K USD
Liabilities 15M USD -56.5%
Retained Earnings (Accumulated Deficit) -31.7M USD -71.4%
Stockholders' Equity Attributable to Parent 42.7M USD -20%
Liabilities and Equity 57.7M USD -34.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.29M USD -366%
Net Cash Provided by (Used in) Financing Activities -53K USD +33.8%
Net Cash Provided by (Used in) Investing Activities -360K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 16.8M shares +0.08%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Operating Lease, Liability 506K USD
Depreciation 17K USD +1600%
Payments to Acquire Property, Plant, and Equipment 360K USD
Lessee, Operating Lease, Liability, to be Paid 550K USD
Property, Plant and Equipment, Gross 1.5M USD
Operating Lease, Liability, Current 241K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 76K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 254K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 44K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 16K USD
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 0 USD
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 17K USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.48M USD +12.4%
Interest Expense 4K USD -97.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%